OTC Gastrointestinal Products Market Report

OTC Gastrointestinal Products Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Feb 17, 2020
  • PAGES：208
  • REPORT CODE：GMM475850
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide OTC Gastrointestinal Products market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.8% during the forecast period.

    This report presents the market size and development trends by detailing the OTC Gastrointestinal Products market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the OTC Gastrointestinal Products market will be shown in this report. In short, this report will comprehensively reveal the characteristics of OTC Gastrointestinal Products industry and will help you to build a panoramic view of the industrial development.

    OTC Gastrointestinal Products Market, By Type:

    • H2 Receptor Antagonists

    • Proton Pump Inhibitors (PPIs)

    OTC Gastrointestinal Products Market, By Application:

    • Hospital Pharmacies

    • Drug Stores

    • Retail Stores

    • E-Commerce

    Some of the leading players are as follows:

    • Novartis

    • Bayer

    • Bristol-Myers Squibb

    • GlaxoSmithKline

    • Merck

    • Pfizer

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 OTC Gastrointestinal Products Market: Technology Type Analysis

    • 4.1 OTC Gastrointestinal Products Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 OTC Gastrointestinal Products Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 H2 Receptor Antagonists

      • 4.3.2 Proton Pump Inhibitors (PPIs)

    5 OTC Gastrointestinal Products Market: Product Analysis

    • 5.1 OTC Gastrointestinal Products Product Market Share Analysis, 2018 & 2026

    • 5.2 OTC Gastrointestinal Products Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 OTC Gastrointestinal Products Market: Application Analysis

    • 6.1 OTC Gastrointestinal Products Application Market Share Analysis, 2018 & 2026

    • 6.2 OTC Gastrointestinal Products Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Hospital Pharmacies

      • 6.3.2 Drug Stores

      • 6.3.3 Retail Stores

      • 6.3.4 E-Commerce

    7 OTC Gastrointestinal Products Market: Regional Analysis

    • 7.1 OTC Gastrointestinal Products Regional Market Share Analysis, 2018 & 2026

    • 7.2 OTC Gastrointestinal Products Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Novartis

      • 9.1.1 Novartis Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Bayer

      • 9.2.1 Bayer Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Bristol-Myers Squibb

      • 9.3.1 Bristol-Myers Squibb Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 GlaxoSmithKline

      • 9.4.1 GlaxoSmithKline Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Merck

      • 9.5.1 Merck Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Pfizer

      • 9.6.1 Pfizer Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

     

    The List of Tables and Figures (Totals 79 Figures and 123 Tables)

    • Figure H2 Receptor Antagonists OTC Gastrointestinal Products market, 2015 - 2026 (USD Million)

    • Figure Proton Pump Inhibitors (PPIs) OTC Gastrointestinal Products market, 2015 - 2026 (USD Million)

    • Figure Hospital Pharmacies market, 2015 - 2026 (USD Million)

    • Figure Drug Stores market, 2015 - 2026 (USD Million)

    • Figure Retail Stores market, 2015 - 2026 (USD Million)

    • Figure E-Commerce market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America OTC Gastrointestinal Products market, by country, 2015 - 2026 (USD Million)

    • Table North America OTC Gastrointestinal Products market, by type, 2015 - 2026 (USD Million)

    • Table North America OTC Gastrointestinal Products market, by product, 2015 - 2026 (USD Million)

    • Table North America OTC Gastrointestinal Products market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. OTC Gastrointestinal Products market, by type, 2015 - 2026 (USD Million)

    • Table U.S. OTC Gastrointestinal Products market, by product, 2015 - 2026 (USD Million)

    • Table U.S. OTC Gastrointestinal Products market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada OTC Gastrointestinal Products market, by type, 2015 - 2026 (USD Million)

    • Table Canada OTC Gastrointestinal Products market, by product, 2015 - 2026 (USD Million)

    • Table Canada OTC Gastrointestinal Products market, by application, 2015 - 2026 (USD Million)

    • Table Europe OTC Gastrointestinal Products market, by country, 2015 - 2026 (USD Million)

    • Table Europe OTC Gastrointestinal Products market, by type, 2015 - 2026 (USD Million)

    • Table Europe OTC Gastrointestinal Products market, by product, 2015 - 2026 (USD Million)

    • Table Europe OTC Gastrointestinal Products market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. OTC Gastrointestinal Products market, by type, 2015 - 2026 (USD Million)

    • Table U.K. OTC Gastrointestinal Products market, by product, 2015 - 2026 (USD Million)

    • Table U.K. OTC Gastrointestinal Products market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany OTC Gastrointestinal Products market, by type, 2015 - 2026 (USD Million)

    • Table Germany OTC Gastrointestinal Products market, by product, 2015 - 2026 (USD Million)

    • Table Germany OTC Gastrointestinal Products market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France OTC Gastrointestinal Products market, by type, 2015 - 2026 (USD Million)

    • Table France OTC Gastrointestinal Products market, by product, 2015 - 2026 (USD Million)

    • Table France OTC Gastrointestinal Products market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy OTC Gastrointestinal Products market, by type, 2015 - 2026 (USD Million)

    • Table Italy OTC Gastrointestinal Products market, by product, 2015 - 2026 (USD Million)

    • Table Italy OTC Gastrointestinal Products market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain OTC Gastrointestinal Products market, by type, 2015 - 2026 (USD Million)

    • Table Spain OTC Gastrointestinal Products market, by product, 2015 - 2026 (USD Million)

    • Table Spain OTC Gastrointestinal Products market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific OTC Gastrointestinal Products market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific OTC Gastrointestinal Products market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific OTC Gastrointestinal Products market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific OTC Gastrointestinal Products market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China OTC Gastrointestinal Products market, by type, 2015 - 2026 (USD Million)

    • Table China OTC Gastrointestinal Products market, by product, 2015 - 2026 (USD Million)

    • Table China OTC Gastrointestinal Products market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan OTC Gastrointestinal Products market, by type, 2015 - 2026 (USD Million)

    • Table Japan OTC Gastrointestinal Products market, by product, 2015 - 2026 (USD Million)

    • Table Japan OTC Gastrointestinal Products market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India OTC Gastrointestinal Products market, by type, 2015 - 2026 (USD Million)

    • Table India OTC Gastrointestinal Products market, by product, 2015 - 2026 (USD Million)

    • Table India OTC Gastrointestinal Products market, by application, 2015 - 2026 (USD Million)

    • Table Latin America OTC Gastrointestinal Products market, by country, 2015 - 2026 (USD Million)

    • Table Latin America OTC Gastrointestinal Products market, by type, 2015 - 2026 (USD Million)

    • Table Latin America OTC Gastrointestinal Products market, by product, 2015 - 2026 (USD Million)

    • Table Latin America OTC Gastrointestinal Products market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil OTC Gastrointestinal Products market, by type, 2015 - 2026 (USD Million)

    • Table Brazil OTC Gastrointestinal Products market, by product, 2015 - 2026 (USD Million)

    • Table Brazil OTC Gastrointestinal Products market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico OTC Gastrointestinal Products market, by type, 2015 - 2026 (USD Million)

    • Table Mexico OTC Gastrointestinal Products market, by product, 2015 - 2026 (USD Million)

    • Table Mexico OTC Gastrointestinal Products market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina OTC Gastrointestinal Products market, by type, 2015 - 2026 (USD Million)

    • Table Argentina OTC Gastrointestinal Products market, by product, 2015 - 2026 (USD Million)

    • Table Argentina OTC Gastrointestinal Products market, by application, 2015 - 2026 (USD Million)

    • Table MEA OTC Gastrointestinal Products market, by country, 2015 - 2026 (USD Million)

    • Table MEA OTC Gastrointestinal Products market, by type, 2015 - 2026 (USD Million)

    • Table MEA OTC Gastrointestinal Products market, by product, 2015 - 2026 (USD Million)

    • Table MEA OTC Gastrointestinal Products market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa OTC Gastrointestinal Products market, by type, 2015 - 2026 (USD Million)

    • Table South Africa OTC Gastrointestinal Products market, by product, 2015 - 2026 (USD Million)

    • Table South Africa OTC Gastrointestinal Products market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria OTC Gastrointestinal Products market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria OTC Gastrointestinal Products market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria OTC Gastrointestinal Products market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Novartis Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bayer Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bristol-Myers Squibb Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Merck Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US